Novartis AG (NVSEF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Basel, Switzerland. The current CEO is Vasant Narasimhan.
NVSEF has IPO date of 2010-04-26, 75,883 full-time employees, listed on the Other OTC, a market capitalization of $298.59B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two primary segments: Innovative Medicines, which offers prescription medications across therapeutic areas including ophthalmology, neuroscience, immunology, cardiovascular, and respiratory medicine, and Sandoz, a leading generics and biosimilars business that manufactures and markets finished pharmaceuticals, active ingredients, and biotechnology-based products. Novartis maintains strategic collaborations with companies such as Alnylam Pharmaceuticals and Kura Oncology to advance its pipeline in areas like RNA interference therapeutics and oncology. The company serves patients, healthcare providers, and third-party pharmaceutical manufacturers across diverse markets globally.
